SARS-CoV-2, polymyalgia rheumatica and giant cell arteritis: COVID-19 vaccine shot as a trigger? Comment on: “Can SARS-CoV-2 trigger relapse of polymyalgia rheumatica?” by Manzo et al. Joint Bone Spine 2021;88:105150 - 02/01/22

Simon Cadiou ^{a, ⁎} , Aleth Perdriger ^a, Samuel Ardois ^b, Jean-David Albert ^{a, c}, Olivia Berthoud ^a, Alain Lescoat ^{b, d}, Pascal Guggenbuhl ^{a, c}, François Robin ^{a, c}

^a Department of rheumatology, Rennes university hospital, university Rennes, Rennes, France 

^b Department of internal medicine and clinical immunology, Rennes university hospital, university Rennes, Rennes, France 

^c Inserm UMR 1241, Inra, Institut NUMECAN (Nutrition Metabolisms and Cancer), university Rennes, 35000 Rennes, France 

^d Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail) – UMR_S 1085, university Rennes, Rennes, France 

^⁎Corresponding author. Hôpital Sud Rennes, 16, boulevard de Bulgarie, 35000 Rennes, France.Hôpital Sud Rennes16, boulevard de BulgarieRennes35000France

Le texte complet de cet article est disponible en PDF.